This is very impressive statements from our CEO who i

New Post Public Reply Private Reply Replies (2) Message Board
BrownMule
759
This is very impressive statements from our CEO who i believe to be a very impressive business man, the man will delivery on what he has stated I'm sure it hasn't been a easy road for him an his associates either.

Been a lot of predictions as to what the PPS will be but myself I will just be happy when all is up an going, the PR's will tell us all an then we could maybe make a reasonable prediction. JMO


Chairman Pres/CEO Univec Conglomerate Inc. 1st Black executive in Chain Drug Store’s - 3 Halls of Fame Senatorial Medal of Freedom -Top 100 IFAH
Jun 21

Don’t worry longs I have a rainbow of dollars for you. Float will dry up . Univec book it. And yes This is your CEO

This is Dr. David Dalton Chairman, President/ CEO leading Univec Conglomerate Inc. to make changes in the Healthcare system. Providing wealth for all and support for The indigent who can’t help themselves yet and to the veterans who have given so much.

Univec Conglomerate Inc. Through our subsidiary PPSI will see our Veterans have access to CBD and Medical Marajuana . Always been part of our plan. Congress didn’t do it. We will make the change.

June 27th: PPSI subsidiary of Univec Conglomerate Inc. Patient assistance for those who can’t afford. Access and Change.

June 28th:The float will dry up . PR will make new beginnings. Univec Conglomerate Inc. Book it

July 6th:A unbelievable schedule .People get on board a express train getting ready to leave. Longs a rainbow Negative Toxic Sorry -short terms sorry. This is Univec Inc. Now Univec Conglomerate Inc . One company your CEO - Dr. David Dalton and Yes this is my account Unvc Book it

July 18th: Answer to a Question
I have never sold a share of our company
Remember you get what you ask for
Ask low get low
Ask high get high
Life has choices

July 23rd: One more goal accomplished
“ Clinically Proven “
Sometimes to finish first is to be last. Univec Conglomerate Inc. Is the old Univec , but now an integrated powerful entity. It will take others years to duplicate. The Gold Standard

July30th: Mylan merger into a new company with Pfizer gives worldwide growth. Most do not know that Mylan’s Operations is in Morgantown, W.Va. where West Virginia University is located .
Most do not know that Mylan invested 1 million into one of our early companies.

Aug. 1st: Love it when auditors and attorneys agree

Aug. 3rd: Financial literacy is very important especially after a rainbow

Aug. 12th: Everyday negative leads to a positive . Believe Univec Conglomerate Inc. Will provide opportunity for Wealth creation for those that have not had the access or opportunity. If it were not true - attention would not be on us. Book it.

Aug. 21st: Tired of bureaucracy and pontification . Expect my Type A personality to deliver for our shareholders . Time for the change. Univec Conglomerate Inc. You can’t stop it. I promised a rainbow. Everyday opportunity for everyday hardworking people . I won’t fail, never , no way.

Aug. 29th: I know patience is very difficult believe me I know. I will be working this holiday. Supply chain and research is important as noted finally by DEA. One additional step completed for Univec Conglomerate Inc. We have some that can’t spell Conglomerate spell Lawsuit.

$$$UNVC$$$

Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 11

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 17

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 22

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 20

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 23

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into Stella-Jones Conference Call for Q3 Results

Updated Category News Views 70

Upcoming Conference Call for Stella-Jones Inc. Stella-Jones Inc. (TSX: SJ), a prominent player in the manufacturing of pressure-treated wood products, is set to hold a significant conference call to discuss its third quarter results. Details of the Conference Call The conference call is open to investors, analysts, and all interested parties. It will take place on...

Continue Reading
Total Voting Rights Announcement for Northern Venture Trust

Updated Category News Views 75

Update on Total Voting Rights Northern Venture Trust PLC has released a key update concerning its total voting rights. In line with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, the Company is informing the market about its present capital structure. Overview of Ordinary Shares As per the latest information, Northern Venture Trust PLC's...

Continue Reading
Northrop Grumman Faces Investor Scrutiny Amid Financial Decline

Updated Category News Views 431

Investor Concerns Around Northrop Grumman Investors holding shares in Northrop Grumman Corporation (NYSE: NOC) are facing critical developments as they are encouraged to evaluate their positions in light of recent financial disclosures and ongoing investigations by legal entities. This alert revolves around Northrop Grumman's recent performance and future implications...

Continue Reading
Nature's Sunshine Welcomes Katie May to Board Leadership

Updated Category News Views 420

Nature's Sunshine Embraces New Leadership with Katie A. May Nature's Sunshine Products, Inc. is thrilled to announce that Katie A. May has joined its board of directors, marking a significant step in enhancing leadership and direction within the company. With a rich background in ecommerce and logistics, Katie's new role reflects the company's commitment to further...

Continue Reading
NewAmsterdam Pharma Announces Participation in Key Investor Conferences

Updated Category News Views 79

NewAmsterdam Pharma to Attend Investor Conferences NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is a leading biopharmaceutical firm committed to creating innovative oral medications designed to reduce low-density lipoprotein (LDL) cholesterol levels for individuals at risk of cardiovascular disease (CVD). The company is preparing for a series of upcoming investor...

Continue Reading